Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-28
2010-11-09
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S396000, C514S406000, C546S275400, C548S304400, C548S373100
Reexamination Certificate
active
07829586
ABSTRACT:
Disclosed is an aryl-substituted nitrogen-containing heterocyclic compound represented by the formula (I) below or a pharmaceutically acceptable salt thereof. This compound serves as nociceptin receptor antagonist and is useful as a pharmaceutical agent for treating diseases associated with a nociceptin receptor. (I)[in the formula, A1, A2and A3independently represent a carbon atom or a nitrogen atom, and one or two of A1, A2and A3represent a carbon atom; R1represents a lower alkyl group or the like; R2represents a phenyl group which may be substituted with a halogen atom or the like; R3represents a hydrogen atom, a lower alkyl group or the like; and R4represents a lower alkyl group or the like.]
REFERENCES:
patent: 5624941 (1997-04-01), Barth et al.
patent: 6525059 (2003-02-01), Anantanarayan et al.
patent: 6960601 (2005-11-01), Smith
patent: 7125877 (2006-10-01), Kobayashi et al.
patent: 2004/0063691 (2004-04-01), Smith et al.
patent: 2002/284779 (2002-10-01), None
patent: WO/006545 (2000-02-01), None
patent: WO/0139775 (2001-06-01), None
K. Kobayashi et al., “Discovery of Novel Arylpyrazole Series as Potent and Selective Opioid Receptor-Like (ORL 1) Antagonists”, vol. 19, pp. 3627-3631, Biorganic & Medicinal Chemistry Letters, 2009.
K. Kobayashi et al., “Identification of MK-1925: A Selective, Orally Active and Brain-Penetrable Opioid Receptor-Like 1 (ORL 1) Antagonist”, vol. 19, pp. 4729-4732, Biorganic & Medicinal Chemistry Letters, 2009.
Ito Hirokatsu
Kobayashi Kensuke
Ohta Hisashi
Okamoto Osamu
Ozaki Satoshi
Banyu Pharmaceutical Co. Ltd.
Devlin Gerard M.
Saeed Kamal A
Shterengarts Samantha L
Thies J. Eric
LandOfFree
Aryl-substituted nitrogen-containing heterocyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl-substituted nitrogen-containing heterocyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl-substituted nitrogen-containing heterocyclic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4202804